17-15738320-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001388465.1(TBC1D26):c.320G>A(p.Arg107Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )
Consequence
TBC1D26
NM_001388465.1 missense
NM_001388465.1 missense
Scores
2
2
15
Clinical Significance
Conservation
PhyloP100: 1.48
Genes affected
TBC1D26 (HGNC:28745): (TBC1 domain family member 26) Predicted to enable GTPase activator activity. Predicted to be involved in activation of GTPase activity and intracellular protein transport. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.796
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBC1D26 | NM_001388465.1 | c.320G>A | p.Arg107Gln | missense_variant | 7/15 | ENST00000437605.4 | NP_001375394.1 | |
ZNF286A-TBC1D26 | NR_171000.1 | n.2509G>A | non_coding_transcript_exon_variant | 14/23 | ||||
TBC1D26-AS1 | XR_001753084.3 | n.150-1771C>T | intron_variant, non_coding_transcript_variant | |||||
TBC1D26 | NM_178571.4 | c.320G>A | p.Arg107Gln | missense_variant | 7/15 | NP_848666.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D26 | ENST00000437605.4 | c.320G>A | p.Arg107Gln | missense_variant | 7/15 | 5 | NM_001388465.1 | ENSP00000410111 | P1 | |
TBC1D26-AS1 | ENST00000434017.1 | n.190-1771C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152032Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152032
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249378Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135302
GnomAD3 exomes
AF:
AC:
1
AN:
249378
Hom.:
AF XY:
AC XY:
1
AN XY:
135302
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461530Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727068
GnomAD4 exome
AF:
AC:
5
AN:
1461530
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
727068
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152032Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74254
GnomAD4 genome
AF:
AC:
1
AN:
152032
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74254
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.320G>A (p.R107Q) alteration is located in exon 7 (coding exon 5) of the TBC1D26 gene. This alteration results from a G to A substitution at nucleotide position 320, causing the arginine (R) at amino acid position 107 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;.
M_CAP
Benign
T
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;H;H
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;.
REVEL
Benign
Sift
Benign
.;T;.
Sift4G
Benign
T;T;T
Polyphen
P;P;P
Vest4
MutPred
Loss of methylation at R107 (P = 0.0244);Loss of methylation at R107 (P = 0.0244);Loss of methylation at R107 (P = 0.0244);
MVP
MPC
0.81
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at